GENOLUTION INC. Logo

GENOLUTION INC.

Develops molecular diagnostics and RNA interference solutions for research and IVD.

225220 | KO

Overview

Corporate Details

ISIN(s):
KR7225220003
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로3길 63 (주)제놀루션, 강서구

Description

Genolution Inc. is a biotechnology company specializing in molecular diagnostics (MDx) and RNA interference (RNAi). The company develops and manufactures In-Vitro Diagnostic (IVD) solutions, including automated nucleic acid extraction systems, reagents, and consumables for genetic testing and life sciences research. Its core offerings support a wide range of applications from clinical diagnostics to genomics. In parallel, Genolution provides RNAi-related products and services, such as double-stranded RNA (dsRNA) synthesis for gene expression studies and agricultural development. The company focuses on creating faster and more affordable solutions for both the diagnostics and research markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-04-03 00:00
주주명부폐쇄기간또는기준일설정
Korean 5.1 KB
2023-03-30 00:00
주식등의대량보유상황보고서(일반)
Korean 109.0 KB
2023-03-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2023-03-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2023-03-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2023-03-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2023-03-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.9 KB
2023-03-24 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.7 KB
2023-03-24 00:00
정기주주총회결과
Korean 26.5 KB
2023-03-24 00:00
[기재정정]사업보고서 (2022.12)
Korean 870.8 KB
2023-03-16 00:00
사업보고서 (2022.12)
Korean 848.8 KB
2023-03-15 00:00
감사보고서제출
Korean 18.2 KB
2023-03-13 00:00
기타경영사항(자율공시)(꿀벌 낭충봉아부패병 유전자 치료제 허니가드-R액의 임상시험 결과)
Korean 16.3 KB
2023-03-03 00:00
주식등의대량보유상황보고서(일반)
Korean 95.7 KB
2023-03-02 00:00
주주총회소집공고
Korean 110.5 KB

Automate Your Workflow. Get a real-time feed of all GENOLUTION INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENOLUTION INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENOLUTION INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.